About Wegovy® Tablets
Wegovy® (semaglutide) is a prescription-only weight loss treatment developed by Novo Nordisk. Until recently, semaglutide was only available as a weekly injection. The tablet form offers the same active ingredient in a once-daily pill, making it a practical option for adults who prefer to avoid injections.
Semaglutide works by mimicking a naturally occurring hormone called GLP-1 (glucagon-like peptide-1). This hormone is released after eating and plays a key role in regulating appetite and blood sugar levels. By activating GLP-1 receptors in the brain, Wegovy® helps reduce hunger, increase feelings of fullness, and lower overall calorie intake.
Wegovy® tablets are intended to be used alongside a reduced-calorie diet and increased physical activity as part of a structured weight management programme. They are prescribed where clinically appropriate following a full medical assessment.
Wegovy® tablets have been approved by the MHRA for weight loss in the UK. They are currently only available via private prescription.
Only logged in customers who have purchased this product may leave a review.
Side Effects
Like all medicines, Wegovy® tablets can cause side effects. Most are mild to moderate and tend to improve as your body adjusts to the medication, particularly during the dose-increase phase.
Common side effects include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Stomach pain or discomfort
- Indigestion or heartburn
- Reduced appetite
- Headache
- Fatigue
- Dizziness
Serious side effects — seek medical advice promptly if you experience:
- Severe or persistent abdominal pain (which may indicate pancreatitis)
- Symptoms of gallbladder problems such as pain in the upper right abdomen, fever, or jaundice
- Signs of a serious allergic reaction such as swelling of the face, lips, or throat, difficulty breathing, or a rapid heartbeat
- Changes in vision (which may indicate diabetic retinopathy complications)
- Signs of low blood sugar if you are also taking insulin or sulfonylureas
- Mood changes, depression, or thoughts of self-harm
This is not a full list of side effects. Read the patient information leaflet supplied with your medication and speak to your prescriber or pharmacist if you have any concerns.
Warnings
Wegovy® tablets are not suitable for everyone. Do not take this medication if you:
- Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Are pregnant, planning to become pregnant, or breastfeeding
- Have a known allergy or serious hypersensitivity to semaglutide or any ingredient in the tablet
Tell your prescriber before starting Wegovy® tablets if you:
- Have or have previously had pancreatitis
- Have gallbladder or kidney problems
- Have diabetic eye disease (retinopathy)
- Have a history of depression, anxiety, or suicidal thoughts
- Are taking other medicines, particularly insulin, sulfonylureas, or any other oral medications (timing of administration may be affected)
- Have any other serious medical conditions
Wegovy® tablets are a prescription-only medicine and are only prescribed following a full clinical assessment. Always follow the guidance of your prescriber and read the patient information leaflet before use.
Reviews
There are no reviews yet.